These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2956411)
1. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug. Urien S; Pinquier JL; Paquette B; Chaumet-Riffaud P; Kiechel JR; Tillement JP J Pharmacol Exp Ther; 1987 Jul; 242(1):349-53. PubMed ID: 2956411 [TBL] [Abstract][Full Text] [Related]
2. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats. Urien S; Morin D; Tillement JP J Pharmacol Exp Ther; 1989 Feb; 248(2):781-5. PubMed ID: 2918479 [TBL] [Abstract][Full Text] [Related]
3. Differential effect of plasma protein binding of bupivacaine on its in vivo transfer into the brain and salivary gland of rats. Terasaki T; Pardridge WM; Denson DD J Pharmacol Exp Ther; 1986 Dec; 239(3):724-9. PubMed ID: 3795038 [TBL] [Abstract][Full Text] [Related]
4. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. Pardridge WM; Mietus LJ J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850 [TBL] [Abstract][Full Text] [Related]
5. Effects of the binding of imipramine to erythrocytes and plasma proteins on its transport through the rat blood-brain barrier. Riant P; Urien S; Albengres E; Renouard A; Tillement JP J Neurochem; 1988 Aug; 51(2):421-5. PubMed ID: 3392536 [TBL] [Abstract][Full Text] [Related]
6. Effect of erythrocytes and plasma protein binding on the transport of progabide and SL 75102 through the rat blood-brain barrier. Hamberger C; Urien S; Essassi D; Grimaldi B; Barre J; Taiclet A; Thenot JP; Tillement JP Biochem Pharmacol; 1987 Aug; 36(16):2641-5. PubMed ID: 3606664 [TBL] [Abstract][Full Text] [Related]
7. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes. Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222 [TBL] [Abstract][Full Text] [Related]
8. Influx of thyroid hormones into rat liver in vivo. Differential availability of thyroxine and triiodothyronine bound by plasma proteins. Pardridge WM; Mietus LJ J Clin Invest; 1980 Aug; 66(2):367-74. PubMed ID: 6772672 [TBL] [Abstract][Full Text] [Related]
9. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases. Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607 [TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog. Niwa T; Tokuma Y; Noguchi H Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108 [TBL] [Abstract][Full Text] [Related]
11. Stereoselective binding of isradipine to human plasma proteins. Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T Chirality; 1995; 7(3):167-72. PubMed ID: 7794694 [TBL] [Abstract][Full Text] [Related]
12. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug. Pardridge WM; Sakiyama R; Fierer G J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493 [TBL] [Abstract][Full Text] [Related]
13. Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery. Jolliet P; Simon N; Brée F; Urien S; Pagliara A; Carrupt PA; Testa B; Tillement JP Pharm Res; 1997 May; 14(5):650-6. PubMed ID: 9165538 [TBL] [Abstract][Full Text] [Related]
14. Influence of blood components on the tissue uptake indices of cyclosporin in rats. Lemaire M; Pardridge WM; Chaudhuri G J Pharmacol Exp Ther; 1988 Feb; 244(2):740-3. PubMed ID: 3346845 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of serum protein binding of felodipine. Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing isradipine and amlodipine binding to human plasma lipoproteins. Oravcova J; Sojkova D; Fetkovska N; Trnovec T Blood Press Suppl; 1994; 1():61-4. PubMed ID: 8205304 [TBL] [Abstract][Full Text] [Related]
17. Enantioselective plasma protein binding of bimoclomol. Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cyclosporine A interactions with human plasma lipoproteins in vitro and in vivo in the rat. Urien S; Zini R; Lemaire M; Tillement JP J Pharmacol Exp Ther; 1990 Apr; 253(1):305-9. PubMed ID: 2329513 [TBL] [Abstract][Full Text] [Related]
19. Increased blood--brain barrier transport of protein-bound anticonvulsant drugs in the newborn. Cornford EM; Pardridge WM; Braun LD; Oldendorf WH J Cereb Blood Flow Metab; 1983 Sep; 3(3):280-6. PubMed ID: 6874737 [TBL] [Abstract][Full Text] [Related]
20. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs. Morse DS; Abernethy DR; Greenblatt DJ Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]